STOCK TITAN
  1. Home
  2. Sec-filings
  3. AVDL
  4. [EFFECT] AVADEL PHARMACEUTICALS PLC SEC Filing

[EFFECT] AVADEL PHARMACEUTICALS PLC SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: February 13, 2026
Accession Number: 0001104659-26-014355
Submission Type: POS AM
CIK: 0001012477
Company Name: AVADEL PHARMACEUTICALS PLC
File Number: 333-183961

Source: View Original Filing on SEC EDGAR

Stock AVDL logo
Avadel Pharmaceu

NASDAQ:AVDL

AVDL Rankings

#2140 Ranked by Market Cap
N/A Ranked by Dividends

AVDL Latest News

Feb 12, 2026
Alkermes plc Completes Acquisition of Avadel Pharmaceuticals plc, Accelerating Entry Into Sleep Medicine Market
Feb 10, 2026
Avadel Pharmaceuticals Announces Outcome of the Court Sanction Hearing
Jan 12, 2026
Avadel Pharmaceuticals Announces that Avadel Shareholders Approve the Proposed Acquisition by Alkermes
Dec 18, 2025
Avadel Pharmaceuticals Announces Completion of Enrollment in Phase 3 REVITALYZ™ Trial in Idiopathic Hypersomnia
Dec 5, 2025
Announcement relating to despatch of Rule 15 proposal

AVDL Latest SEC Filings

Feb 17, 2026
[SCHEDULE 13G/A] AVADEL PHARMACEUTICALS PLC Amended Passive Investment Disclosure
Feb 17, 2026
[EFFECT] AVADEL PHARMACEUTICALS PLC SEC Filing
Feb 17, 2026
[EFFECT] AVADEL PHARMACEUTICALS PLC SEC Filing
Feb 17, 2026
[EFFECT] AVADEL PHARMACEUTICALS PLC SEC Filing
Feb 12, 2026
[Form 4] AVADEL PHARMACEUTICALS PLC Insider Trading Activity

AVDL Stock Data

2.12B
98.15M
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
Ireland
DUBLIN 2